Vicarious Surgical Stock (NYSE:RBOT)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$2.49

52W Range

$1.80 - $16.35

50D Avg

$2.67

200D Avg

$6.05

Market Cap

$16.22M

Avg Vol (3M)

$142.80K

Beta

1.53

Div Yield

-

RBOT Company Profile

Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

123

IPO Date

Sep 04, 2020

Website

RBOT Performance

RBOT Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-66.56M	$-80.67M	$-80.08M
Net Income	$-63.22M	$-71.07M	$89.16M
EBITDA	$-66.56M	$-69.19M	$7.30M
Basic EPS	$-10.74	$-14.70	$20.77
Diluted EPS	$-10.74	$-14.60	$20.99

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q3 25Nov 12, 25 | 4:30 PM

Q2 25Aug 12, 25 | 4:30 PM

Q1 25May 12, 25 | 4:30 PM

Peer Comparison

Ticker	Company
INTS	Intensity Therapeutics, Inc.
HYPD	Hyperion DeFi, Inc.
PIII	P3 Health Partners Inc.
QTTB	Q32 Bio Inc.
MODD	Modular Medical, Inc.
BOLD	Boundless Bio, Inc.
NXL	Nexalin Technology, Inc.
ITRM	Iterum Therapeutics plc
PSTV	Plus Therapeutics, Inc.